カナダのジェネリック医薬品産業プロファイルでは、市場規模(2018〜2023年の値、および2028年までの予測)などのトップラインの定性的および定量的概要情報が提供されます。プロファイルには、主要な財務指標や市場内の競争圧力の分析など、主要企業の説明も含まれています。
目次
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths and strategies of the leading players?
7.3. What are the most recent generic drugs launched in the market?
8 Company Profiles
8.1. Teva Canada Ltd
8.2. Apotex Inc
8.3. Sandoz Canada Inc
8.4. Viatris Inc
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Canada generics market value: $ million, 2018-23
Table 2: Canada generics market volume: % of total pharma volume, 2018-23
Table 3: Canada generics market geography segmentation: $ million, 2023
Table 4: Canada generics market value forecast: $ million, 2023-28
Table 5: Canada generics market volume forecast: % of total pharma volume, 2023-28
Table 6: Teva Canada Ltd: Key Facts
Table 7: Teva Canada Ltd: Key Employees
Table 8: Apotex Inc: Key Facts
Table 9: Apotex Inc: Key Employees
Table 10: Sandoz Canada Inc: Key Facts
Table 11: Sandoz Canada Inc: Key Employees
Table 12: Viatris Inc: Key Facts
Table 13: Viatris Inc: Annual Financial Ratios
Table 14: Viatris Inc: Key Employees
Table 15: Canada Size of Population (million), 2019-23
Table 16: Canada Real GDP (Constant 2010 Prices, $ Billion), 2019-23
Table 17: Canada GDP (Current Prices, $ Billion), 2019-23
Table 18: Canada Inflation, 2019-23
Table 19: Canada Consumer Price Index (Absolute), 2019-23
Table 20: Canada Exchange Rate, 2018-23
List of Figures
Figure 1: Canada generics market value: $ million, 2018-23
Figure 2: Canada generics market volume: % of total pharma volume, 2018-23
Figure 3: Canada generics market geography segmentation: % share, by value, 2023
Figure 4: Canada generics market value forecast: $ million, 2023-28
Figure 5: Canada generics market volume forecast: % of total pharma volume, 2023-28
Figure 6: Forces driving competition in the generics market in Canada, 2023
Figure 7: Drivers of buyer power in the generics market in Canada, 2023
Figure 8: Drivers of supplier power in the generics market in Canada, 2023
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Canada, 2023
Figure 10: Factors influencing the threat of substitutes in the generics market in Canada, 2023
Figure 11: Drivers of degree of rivalry in the generics market in Canada, 2023